The boys are back together #AUA2022 @brady_urology

Adding to the good news of enrolling our first patient, the FDA has just designated SkinTE a Regenerative Medicine Advanced Therapy. #RMATs are novel regenerative therapies that address unmet needs, which SkinTE demonstrated in our prior clinical data.

We are excited to announce the enrollment of our first patient in our Phase III Pivotal Study evaluating Investigational New Drug SkinTE for the treatment of diabetic foot ulcers. We are incredibly thankful for the patients and investigators.

Shelby Powers from Dr. Hannan’s lab shows loss of regenerative capacity of pelvic ganglia neurons following radiation. #AUA18 @Hannan_Lab @SAPowers123 @jsexmed

Dr. Matz presents preclinical data showing sustained erectile improvement with off the shelf human placental stem cell. #AUA18 @wakeurology @jsexmed

Dr. Liu shows preliminary preclinical results showing loss of function with penile Botox injections raising important questions. #AUA18 @brady_urology @jsexmed

Dr. Bivalacqua presents final results of Phase I neourinary conduit trial. Very promising results but still needs optimization. #aua18 @brady_urology @tbivala1 @DrGreg_MD

Dr. Bivalacqua @tbivala1 presenting the complex regulatory scheme of biological therapies @brady_urology #smsna2017

Dr. Joice presenting work on AUS component replacement. #smsna2017 @brady_urology

Atrogin protein and Wnt-beta catenin are increased in age related urethral sphincter fibrosis by Dr. Rajasekaran #AUA17